ENVISTA HOLDINGS CORPORATION
In the published model solve dated 2026-Q2, anchored at $28.65, ENVISTA HOLDINGS CORPORATION (NVST) is priced for +15.9% growth. boothcheck publishes no house fair value, target price, or buy/sell rating; individual model outputs and user-controlled scenarios are analytical inputs, not Boothcheck targets. The narrative was composed June 27, 2026 from SEC EDGAR filings.
• Envista is a dental products company spanning implants, clear-aligner orthodontics, and everyday consumables, and it has now posted four straight quarters of growth across all of its major businesses. [Source: Envista Q1 2026 results, May 2026] • The clearest risk is operating leverage off a thin base: the trailing operating margin sits around 8.5%, so the recovery thesis depends on margins expanding from a low level rather than on a fortress profitability already in place. • Watch core growth
Is NVST overvalued? See what's priced in →
375 institutional managers reported holding NVST in 13F filings for the quarter ended 2026-03-31. 83 opened new positions that quarter. Held by BlackRock, Vanguard Group, Dimensional Fund Advisors, among others. On the short side, 12.1M shares were sold short as of the 2026-06-15 count, about 7% of shares outstanding (4.6 days of typical volume to cover).
Quarterly 13F filings arrive up to 45 days after quarter end, so the picture is never current (filed through 2026-05-29). Nothing here is investment advice.
NVST's share count grew 1.7% over the past five years even with $228.30M spent on repurchases. It pays no dividend. Cash returned over the past three years: $228.30M in repurchases.
Share counts are split-adjusted; repurchase totals are gross of share issuance. Nothing here is investment advice.
Open-market insider buys at NVST over the trailing three years: 2023: 9 buys totaling $417k; 2024: 2 buys totaling $907k. 16 officers and directors are on file.
Code P open-market purchases from SEC Form 4 filings, non-derivative, excluding scheduled 10b5-1 plans. Nothing here is investment advice.
NVST's recent reports: the day-one move, then what the following quarter actually did.
| report | day one | next quarter |
|---|---|---|
| 2023-08-03 | +0.8% | -25.2% |
| 2023-11-02 | -8.7% | +10.0% |
| 2024-02-16 | -8.5% | -11.4% |
| 2024-05-02 | +0.7% | -17.8% |
Day-one is the close-to-close move around the filing. Nothing here is investment advice.
NVST's latest 8-K filings: 2026-08-05 (items 2.02, 7.01, 9.01); 2026-06-03 (items 5.02, 9.01); 2026-05-21 (items 5.07, 9.01); 2026-05-06 (items 2.02, 7.01, 9.01); 2026-02-05 (items 2.02, 7.01, 9.01).
Item codes are the SEC's own classification of what each report discloses. Dates link to the filing on EDGAR. Nothing here is investment advice.
Model solve date: 2026-Q2
Narrative composed: June 27, 2026
Each week boothcheck ranks the stocks whose prices are betting on the most. Read the most stretched bets archive →
boothcheck is also on Android. Get the app on Google Play →
For informational and research purposes only. Not investment advice. Not a recommendation to buy, sell, or hold any security. boothcheck is not a registered investment adviser. Past performance does not guarantee future results.